Ionis Pharmaceuticals (IONS) EBITDA US GAAP (year values) |
|||||||||
2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
EBITDA, bln rub | ? | 411.5 | -107.9 | -0.239 | -227.8 | -230.0 | -252.6 | ||
Changes by years, y/y, % | -769% | -126% | -100% | +95 196% | +1% | +30.2% |
Ionis Pharmaceuticals. EBITDA US GAAP, bln rub
Ionis Pharmaceuticals. EBITDA US GAAP, changes, %
Ionis Pharmaceuticals. EBITDA US GAAP, sum by quarters, bln rub
Ionis Pharmaceuticals (IONS) EBITDA US GAAP (quarter values) |
||||||||
2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
EBITDA, bln rub | ? | -113.2 | 25.2 | -115.0 | -37.8 | -125.0 | -252.6 | |
Changes by years, y/y, % | +123% | -107% | +19% | -36% | +10% | |||
Changes by quarters, q/q, % | +92% | -122% | -557% | -67% | +230% |